Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (Q37352347)

From Wikidata

Jump to navigation Jump to search

scientific article published on 30 March 2016

Language	Label	Description	Also known as
English	Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR).	scientific article published on 30 March 2016

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Drug survival of biologic therapy in a large, disease-based registry of patients with psoriasis: results from the Psoriasis Longitudinal Assessment and Registry (PSOLAR). (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Melinda Gooderham

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

author name string

A Menter

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

D M Pariser

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

M Augustin

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

F A Kerdel

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

S Fakharzadeh

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

K Goyal

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

S Calabro

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

W Langholff

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

S Chavers

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

D Naessens

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

J Sermon

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

G G Krueger

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

language of work or name

1 reference

based on heuristic

inferred from title

publication date

30 March 2016

1 reference

Europe PubMed Central

19 August 2017

Journal of the European Academy of Dermatology and Venereology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

30

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

1148-1158

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:27027388%20AND%20SRC:MED&resulttype=core&format=json

2 June 2020

Demography, baseline disease characteristics and treatment history of patients with psoriasis enrolled in a multicentre, prospective, disease-based registry (PSOLAR)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Efficacy and safety of the anti-IL-12/23 p40 monoclonal antibody, ustekinumab, in patients with active psoriatic arthritis despite conventional non-biological and biological anti-tumour necrosis factor therapy: 6-month and 1-year results of the phas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Antidrug antibodies in psoriasis: a systematic review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Effect of certolizumab pegol on signs and symptoms in patients with psoriatic arthritis: 24-week results of a Phase 3 double-blind randomised placebo-controlled study (RAPID-PsA).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Insights into the efficacy of golimumab plus methotrexate in patients with active rheumatoid arthritis who discontinued prior anti-tumour necrosis factor therapy: post-hoc analyses from the GO-AFTER study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Biologic fatigue in psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Treatment patterns with etanercept and adalimumab for psoriatic diseases in a real-world setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Patient-reported reasons for the discontinuation of commonly used treatments for moderate to severe psoriasis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Ustekinumab in clinical practice: response depends on dose and previous treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Effectiveness and safety of adalimumab in patients with ankylosing spondylitis or psoriatic arthritis and history of anti-tumor necrosis factor therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

6 September 2017

Comparative effectiveness of biologic agents for the treatment of psoriasis in a real-world setting: Results from a large, prospective, observational study (Psoriasis Longitudinal Assessment and Registry [PSOLAR]).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

14 September 2017

Differential Drug Survival of Biologic Therapies for the Treatment of Psoriasis: A Prospective Observational Cohort Study from the British Association of Dermatologists Biologic Interventions Register (BADBIR).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

28 September 2017

Comparison of long-term drug survival and safety of biologic agents in patients with psoriasis vulgaris.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

'Happy' drug survival of adalimumab, etanercept and ustekinumab in psoriasis in daily practice care: results from the BioCAPTURE network.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

Drug survival is not significantly different between biologics in patients with psoriasis vulgaris: a single-centre database analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

Adalimumab for the treatment of psoriasis in real life: a retrospective cohort of 119 patients at a single Spanish centre.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

Survival rate of antitumour necrosis factor-α treatments for psoriasis in routine dermatological practice: a multicentre observational study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

PSOLAR: design, utility, and preliminary results of a prospective, international, disease-based registry of patients with psoriasis who are receiving, or are candidates for, conventional systemic treatments or biologic agents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

Responses to ustekinumab in the anti-TNF agent-naïve vs. anti-TNF agent-exposed patients with psoriasis vulgaris.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5071685

2 September 2018

Ustekinumab dosing, persistence, and discontinuation patterns in patients with moderate-to-severe psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A comparison of psoriasis drug failure rates and reasons for discontinuation in biologics vs conventional systemic therapies

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Survival rate of etanercept for psoriasis in real life: a multicentre observational study

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of adalimumab drug survival in psoriasis differ by reason for discontinuation: long-term results from the Bio-CAPTURE registry

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Drug survival rates in patients with psoriasis after treatment with biologics

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of drug survival rates for adalimumab, etanercept and infliximab in patients with psoriasis vulgaris

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Determinants of drug survival for etanercept in a long-term daily practice cohort of patients with psoriasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/27027388

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1111/JDV.13611

1 reference

https://api.fatcat.wiki/v0/release/s6ar3nyk65abxpjftycy5yh23a

30 July 2022

based on heuristic

mapped directly with Wikidata item

release_s6ar3nyk65abxpjftycy5yh23a

1 reference

https://api.fatcat.wiki/v0/release/s6ar3nyk65abxpjftycy5yh23a

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/s6ar3nyk65abxpjftycy5yh23a

30 July 2022

based on heuristic

mapped directly with Wikidata item

1 reference

https://api.fatcat.wiki/v0/release/s6ar3nyk65abxpjftycy5yh23a

30 July 2022

based on heuristic

mapped directly with Wikidata item

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37352347&oldid=1801469870"